BioEngine was ranked on "2023 Future Healthcare VB100 list"

On May 5-7, 2023, the 7th “Future Healthcare VB100”, organized by VB100, VBData and VCBeat Research and supported by Shanghai Zhangjiang Group, was grandly held in Shanghai Zhangjiang Science Hall. On the evening of May 6, the "2023 Future Healthcare VB100 list” was officially announced. As an advocate and pioneer of China  serum-free culture media, BioEngine was ranked in the "Top 100 Medical Commerce and Supply Chain Service Companies" by virtue of its outstanding research and development platform, and production and supply capacity of cell culture media.

“Top 100 Medical Commerce and Supply Chain Service Companies” is the first domestic innovative healthcare list for non-listed companies launched by VB100, VBData and VCBeat Research. It aims to select Chinese innovative healthcare players that truly represent the future of healthcare, discover the core strengths of China's future healthcare industry, and promote the process of innovation and transformation the healthcare industry.